Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic

BACKGROUND: Poor antipsychotic (AP) adherence is a key issue in patients with schizophrenia. First-generation antipsychotic (FGA) and second-generation antipsychotic (SGA) long-acting injectable therapies (LAI) may improve adherence compared to oral antipsychotics (OAP). The objective of the study w...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Patient Prefer Adherence
Main Authors: Pilon, Dominic, Joshi, Kruti, Tandon, Neeta, Lafeuille, Marie-Hélène, Kamstra, Rhiannon L, Emond, Bruno, Lefebvre, Patrick
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2017
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5367457/
https://ncbi.nlm.nih.gov/pubmed/28356723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S127623
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares